Cohen Steven R, Hewett Sierra, Ross Lauren, Delaunay Flore, Goodacre Ashley, Ramos Char, Leong Tracy, Saad Ahmad
Division of Plastic Surgery, University of California at San Diego, San Diego, CA.
University of California at San Diego, San Diego, CA.
Aesthet Surg J. 2017 Jul 1;37(suppl_3):S16-S32. doi: 10.1093/asj/sjx078.
Zuk et al in 2001 identified stem and regenerative cells within the stromal vascular fraction of fat. In preclinical studies, these cells appeared to stimulate angiogenesis and reduce inflammation, and soon thereafter, clinical use of stromal vascular fraction (SVF) evolved as researchers such as Rigotti, Coleman, Mojallal, our group, and others demonstrated that fat can be used for both therapeutic and aesthetic indications. The regenerative effects of fat and its contents on facial aesthetics have been shown at the histologic and cellular level. Regeneration of elastin and collagen fibers as well as improvement in capillary density and reduction of inflammation have been reported. We review our current approach to the use of regenerative cells and different types of fat grafts in facial surgery. The fat graft is classified, both from a regenerative point of view as well as a tissue product that can be modified into different tissue characteristics, depending on the area and condition treated. Clinical use of SVF enriched fat, millifat, microfat, and nanofat grafts as well as composite fat grafts are reviewed. Based on clinical experience and evidence to date, it appears that the regenerative effects seen with the use of SVF in aesthetic surgery are modest, but there appear to be definite histologic findings of regeneration. These improvements may not be clinically apparent to a patient when cell enriched fat grafts are compared to fat grafts alone. However, the subtle changes seen in histology may be cumulative over time. Three types of fat grafts are defined: millifat (parcel size 2.4<), microfat (1.2<), and nanofat (400-600 μm). Each are characterized by their injectability ratings and emulsification parcel size as well as amount of sSVF cells. Newer concepts of periosteal fat grafting, buccal fat pad grafting, pyriform aperture fat grafting, intraorbital fat grafting, and nanofat grafting are discussed. Composite fat grafts are presented as a new concept as is biofilling and biocontouring. The use of regenerative cells in facial surgery is evolving rapidly. Our understanding of the anatomic changes that occur with aging has become more precise and our ability to target histologic changes seen with aging has become more effective. Deep fat compartment grafting, superficial fat grafting, nanofat, and SVF are becoming important components of contemporary facial rejuvenation. The use of regenerative approaches in facial rejuvenation is a logical step in changing the paradigm from surgical treatment of aging to a more proactive prevention and maintenance approach that keeps up with changes in the tissues as they age.
祖克等人在2001年在脂肪的基质血管成分中鉴定出了干细胞和再生细胞。在临床前研究中,这些细胞似乎能刺激血管生成并减轻炎症,此后不久,随着里戈蒂、科尔曼、莫贾拉尔、我们团队以及其他研究人员证明脂肪可用于治疗和美容适应症,基质血管成分(SVF)的临床应用逐渐发展起来。脂肪及其成分对面部美学的再生作用已在组织学和细胞水平得到证实。有报道称弹性蛋白和胶原纤维得到再生,毛细血管密度提高,炎症减轻。我们回顾了目前在面部手术中使用再生细胞和不同类型脂肪移植的方法。从再生角度以及根据可根据治疗区域和状况改变为不同组织特征的组织产品角度对脂肪移植进行分类。对富含SVF的脂肪、微脂肪、纳米脂肪移植以及复合脂肪移植的临床应用进行了综述。根据目前的临床经验和证据,在美容手术中使用SVF所见到的再生效果似乎并不显著,但确实存在明确的再生组织学表现。当将富含细胞的脂肪移植与单纯脂肪移植进行比较时,这些改善对患者来说在临床上可能并不明显。然而,组织学上看到的细微变化可能会随着时间累积。定义了三种类型的脂肪移植:微脂肪(颗粒大小2.4<)、微脂肪(1.2<)和纳米脂肪(400 - 600μm)。每种脂肪移植都以其注射评级、乳化颗粒大小以及小颗粒脂肪(sSVF)细胞数量为特征。讨论了骨膜脂肪移植、颊脂垫移植、梨状孔脂肪移植、眶内脂肪移植和纳米脂肪移植的新概念。复合脂肪移植作为一个新概念以及生物填充和生物轮廓塑造也被提及。面部手术中再生细胞的应用正在迅速发展。我们对衰老过程中发生的解剖学变化的理解变得更加精确,我们针对衰老所见到的组织学变化的能力也变得更加有效。深部脂肪间隔移植、浅表脂肪移植、纳米脂肪和SVF正成为当代面部年轻化的重要组成部分。在面部年轻化中使用再生方法是将从衰老的手术治疗模式转变为更积极的预防和维持模式的合理步骤,这种模式能够跟上组织随着年龄增长而发生的变化。